Contemporary risk of biochemical recurrence after radical prostatectomy in the active surveillance era
- 15 March 2024
- journal article
- research article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 42 (6) , 175.e1-175.e8
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- Cedars-Sinai Medical Center
This publication has 22 references indexed in Scilit:
- Time Trends in Use of Radical Prostatectomy by Tumor Risk and Life Expectancy in a National Veterans Affairs CohortJAMA Network Open, 2021
- Contemporary Trends in Magnetic Resonance Imaging at the Time of Prostate Biopsy: Results from a Large Private Insurance DatabaseEuropean Urology Focus, 2021
- Trends in Diagnosis and Disparities in Initial Management of High-Risk Prostate Cancer in the USJAMA Network Open, 2020
- Association Between Guideline-Discordant Prostate Cancer Imaging Rates and Health Care Service Among Veterans and Medicare RecipientsJAMA Network Open, 2018
- Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015JAMA, 2018
- A New Risk Classification System for Therapeutic Decision Making with Intermediate-risk Prostate Cancer Patients Undergoing Dose-escalated External-beam Radiation TherapyEuropean Urology, 2013
- A nomogram predicting long‐term biochemical recurrence after radical prostatectomyCancer, 2008
- Anatomic radical retropubic prostatectomy—long-term recurrence-free survival rates for localized prostate cancerWorld Journal of Urology, 2006
- Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate CancerJAMA, 1998
- Validation of a combined comorbidity indexJournal of Clinical Epidemiology, 1994